DESCRIPTION:
A review of the recent progress in adjuvant and neoadjvuant immunotherapy for melanoma, including our own work in the field from the melanoma research group at the University of Pennsylvania
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
• To understand the treatment options for the peri-operative management of high risk melanoma
• To understand the data from randomized trials of neoadjuvant immunotherapy for melanoma